RxDoctor Payments Data

Michael Oneill, MD

Family Medicine · Monument, CONPI 1215943808

Payments from drug & device makers

$2,684in general payments, 2019–2025

Across 64 payments — averaging $41.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$2K
  • Novo Nordisk$242
  • Lilly USA, LLC$122
  • Pfizer$115
  • Sanofi-aventis U.S. LLC$105
  • AbbVie$98
  • plus $441 from 14 others

What the payments were for

  • Travel & lodging$1,38051%
  • Food & beverage$1,30449%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,684 in reported general payments places this provider in the 85th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$50,113
Medicare patients
121
Services billed
509

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole12$34,935
EliquisApixaban24$23,847
OzempicSemaglutide22$21,953
VraylarCariprazine Hcl12$20,116
Breo ElliptaFluticasone/Vilanterol13$5,510
NucyntaTapentadol Hcl12$3,074
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$2,538
Methylphenidate ErMethylphenidate Hcl15$1,438
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen32$1,428
Clonidine18$1,277
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$1,197
Nano 2nd Gen Pen NeedlePen Needle, Diabetic11$679
Losartan Potassium52$664
Omeprazole26$553
Amlodipine Besylate70$498

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$12$34,93512 claims
PfizerEliquis$115$23,84724 claims
Novo NordiskOzempic$242$21,95322 claims
AbbVieVraylar$98$20,11612 claims
GSKBreo Ellipta$17$5,51013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Monument

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →